Paper28525367
Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.
Sarfraz M and 7 others. Oncotarget, 2017. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma. Papers, record 28525367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28525367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Cardiotoxicity | Major topic |
| Doxorubicin | Major topic |
| Liposomes | Major topic |
| Liver Neoplasms | Major topic |
| Oleanolic Acid | Major topic |
| Protective Agents | Major topic |
| Animals | |
| Apoptosis | |
| Cell Line, Tumor | |
| Cell Survival | |
| Disease Models, Animal | |
| Drug Liberation | |
| Drug Stability | |
| Drug Synergism | |
| Female | |
| Humans | |
| Mice | |
| Models, Biological | |
| Myocytes, Cardiac | |
| Xenograft Model Antitumor Assays |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24640601 | Pharmacokinetic evaluation of intraperitoneal doxorubicin in rats. | Pharmazie | 2014 | https://conductscience.org/library/papers/24640601 | PubMed |
| 2 | 23091615 | Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction. | PLoS One | 2012 | https://conductscience.org/library/papers/23091615 | PubMed |
| 3 | 23641057 | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | J Am Soc Nephrol | 2013 | https://conductscience.org/library/papers/23641057 | PubMed |
| 4 | 20016174 | Doxorubicin cardiomyopathy. | Cardiology | 2010 | https://conductscience.org/library/papers/20016174 | PubMed |
| 5 | 23099736 | Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis. | J Gastrointest Surg | 2012 | https://conductscience.org/library/papers/23099736 | PubMed |
| 6 | 26010090 | Simple amides of oleanolic acid as effective penetration enhancers. | PLoS One | 2015 | https://conductscience.org/library/papers/26010090 | PubMed |
| 7 | 27626176 | Combination treatment including targeted therapy for advanced hepatocellular carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27626176 | PubMed |
| 8 | 27013909 | Remote loading of doxorubicin into liposomes by transmembrane pH gradient to reduce toxicity toward H9c2 cells. | Saudi Pharm J | 2016 | https://conductscience.org/library/papers/27013909 | PubMed |
| 9 | 34156 | NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/34156 | PubMed |
| 10 | 25026246 | A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment. | Drug Dev Ind Pharm | 2015 | https://conductscience.org/library/papers/25026246 | PubMed |
| 11 | 20930591 | 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension. | J Cardiovasc Pharmacol | 2010 | https://conductscience.org/library/papers/20930591 | PubMed |
| 12 | 25705903 | Advances and challenges in the use of nanoparticles to optimize PK/PD interactions of combined anti-cancer therapies. | Curr Drug Metab | 2014 | https://conductscience.org/library/papers/25705903 | PubMed |
| 13 | 27114433 | Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. | Gut Liver | 2016 | https://conductscience.org/library/papers/27114433 | PubMed |
| 14 | 21571947 | Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver. | Drug Metab Dispos | 2011 | https://conductscience.org/library/papers/21571947 | PubMed |
| 15 | 23404993 | Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. | Carcinogenesis | 2013 | https://conductscience.org/library/papers/23404993 | PubMed |
| 16 | 17163409 | Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. | Biopharm Drug Dispos | 2007 | https://conductscience.org/library/papers/17163409 | PubMed |
| 17 | 27911871 | Inhibition of cancer antioxidant defense by natural compounds. | Oncotarget | 2017 | https://conductscience.org/library/papers/27911871 | PubMed |
| 18 | 21619582 | Recent advances in nanoparticle formulation of oleanolic acid. | Chin Med | 2011 | https://conductscience.org/library/papers/21619582 | PubMed |
| 19 | 10581328 | Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. | Pharmacol Rev | 1999 | https://conductscience.org/library/papers/10581328 | PubMed |
| 20 | 11574626 | Cancer chemoprevention as adjuvant therapy for hepatocellular carcinoma. | Jpn J Clin Oncol | 2001 | https://conductscience.org/library/papers/11574626 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41126843 | Toward multifunctional nanoplatforms based on layered double hydroxides (LDHs) for cancer therapy: From structural design to application. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41126843 | PubMed |
| 40785948 | Application of Nanotechnology in TACE Treatment of Liver Cancer. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40785948 | PubMed |
| 40718638 | Tetrahedral Framework Nucleic Acids Inhibit Oxidative Stress and Cardiomyocyte Apoptosis in Doxorubicin-Induced Cardiotoxicity. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40718638 | PubMed |
| 39926108 | Exploring the therapeutic potential of oleanolic acid and its derivatives in cancer treatment: a comprehensive review. | 3 Biotech | 2025 | https://conductscience.org/library/papers/39926108 | PubMed |
| 39199418 | Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199418 | PubMed |
| 37375753 | Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37375753 | PubMed |
| 37111802 | Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111802 | PubMed |
| 36014698 | Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes-A Preliminary Study. | Nanomaterials (Basel) | 2022 | https://conductscience.org/library/papers/36014698 | PubMed |
| 35646705 | 3,5,3'-Triiodothyronine-Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages. | Front Oncol | 2022 | https://conductscience.org/library/papers/35646705 | PubMed |
| 35631694 | Reparative Efficacy of Liposome-Encapsulated Oleanolic Acid against Liver Inflammation Induced by Fine Ambient Particulate Matter and Alcohol in Mice. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35631694 | PubMed |
| 35248080 | Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. | J Nanobiotechnology | 2022 | https://conductscience.org/library/papers/35248080 | PubMed |
| 35163063 | The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163063 | PubMed |
| 35009024 | Systematic Review of Potential Anticancerous Activities of Erythrina senegalensis DC (Fabaceae). | Plants (Basel) | 2021 | https://conductscience.org/library/papers/35009024 | PubMed |
| 33801096 | Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies. | Molecules | 2021 | https://conductscience.org/library/papers/33801096 | PubMed |
| 32473991 | Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/32473991 | PubMed |
| 32184597 | Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities. | Int J Nanomedicine | 2020 | https://conductscience.org/library/papers/32184597 | PubMed |
| 31239661 | Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity. | Int J Nanomedicine | 2019 | https://conductscience.org/library/papers/31239661 | PubMed |
| 30551617 | SPC Liposomes as Possible Delivery Systems for Improving Bioavailability of the Natural Sesquiterpene β-Caryophyllene: Lamellarity and Drug-Loading as Key Features for a Rational Drug Delivery Design. | Pharmaceutics | 2018 | https://conductscience.org/library/papers/30551617 | PubMed |
| 30542395 | Cellular viability and osteogenic differentiation potential of human gingiva-derived stem cells in 2D culture following treatment with anionic, cationic, and neutral liposomes containing doxorubicin. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/30542395 | PubMed |
| 30271120 | Chemotherapeutic drug targeting to lungs by way of microspheres after intravenous administration. | Drug Des Devel Ther | 2018 | https://conductscience.org/library/papers/30271120 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MT-CO2 | 4513 | PubTator's text mining | https://conductscience.org/library/genes/4513 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28525367
GET https://conductscience.org/api/papers/v1/28525367/references?page=2